NYMOX
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98369302
- Registration number
- 7578462
- Mark type
- Stylized text
- Filed
- 22 Jan 2024
- Published for opposition
- 09 Jul 2024
- Registered
- 26 Nov 2024
- Attorney of record
- Patrick J. Jennings
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Testing of pharmaceuticals; Medical and scientific research in the field of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
Owner
- Nymox Pharmaceutical Corporation, Nassau, BS
- Nymox Pharmaceutical Corporation, Nassau, BS
- Nymox Pharmaceutical Corporation, Nassau, BS
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 18 Sept 2024 — WITHDRAWN FROM ISSUE - OG REVIEW QUERY
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2024 — ASSIGNED TO EXAMINER
- 22 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Jan 2024 — NEW APPLICATION ENTERED